IBDEI0UA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14679,1,3,0)
 ;;=3^PPD Skin Test
 ;;^UTILITY(U,$J,358.3,14680,0)
 ;;=96372^^78^909^13^^^^1
 ;;^UTILITY(U,$J,358.3,14680,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14680,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,14680,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,14681,0)
 ;;=90714^^78^909^11^^^^1
 ;;^UTILITY(U,$J,358.3,14681,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14681,1,2,0)
 ;;=2^90714
 ;;^UTILITY(U,$J,358.3,14681,1,3,0)
 ;;=3^TD Vaccine
 ;;^UTILITY(U,$J,358.3,14682,0)
 ;;=90656^^78^909^3^^^^1
 ;;^UTILITY(U,$J,358.3,14682,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14682,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,14682,1,3,0)
 ;;=3^Flu Vaccine Single Dose Syringe (Afluria)
 ;;^UTILITY(U,$J,358.3,14683,0)
 ;;=90662^^78^909^1^^^^1
 ;;^UTILITY(U,$J,358.3,14683,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14683,1,2,0)
 ;;=2^90662
 ;;^UTILITY(U,$J,358.3,14683,1,3,0)
 ;;=3^Flu Vaccine High Dose Syringe (Fluzone)
 ;;^UTILITY(U,$J,358.3,14684,0)
 ;;=97530^^78^910^1^^^^1
 ;;^UTILITY(U,$J,358.3,14684,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14684,1,2,0)
 ;;=2^97530
 ;;^UTILITY(U,$J,358.3,14684,1,3,0)
 ;;=3^THERAPEUTIC ACTIVITIES EA 15MIN
 ;;^UTILITY(U,$J,358.3,14685,0)
 ;;=97110^^78^910^2^^^^1
 ;;^UTILITY(U,$J,358.3,14685,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14685,1,2,0)
 ;;=2^97110
 ;;^UTILITY(U,$J,358.3,14685,1,3,0)
 ;;=3^THERAPEUTIC EXERCISES EA 15MIN
 ;;^UTILITY(U,$J,358.3,14686,0)
 ;;=97003^^78^910^3^^^^1
 ;;^UTILITY(U,$J,358.3,14686,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14686,1,2,0)
 ;;=2^97003
 ;;^UTILITY(U,$J,358.3,14686,1,3,0)
 ;;=3^OT EVALUATION
 ;;^UTILITY(U,$J,358.3,14687,0)
 ;;=97001^^78^910^4^^^^1
 ;;^UTILITY(U,$J,358.3,14687,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14687,1,2,0)
 ;;=2^97001
 ;;^UTILITY(U,$J,358.3,14687,1,3,0)
 ;;=3^PT EVALUATION
 ;;^UTILITY(U,$J,358.3,14688,0)
 ;;=97113^^78^910^5^^^^1
 ;;^UTILITY(U,$J,358.3,14688,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14688,1,2,0)
 ;;=2^97113
 ;;^UTILITY(U,$J,358.3,14688,1,3,0)
 ;;=3^AQUATIC THERAPY/EXERCISES
 ;;^UTILITY(U,$J,358.3,14689,0)
 ;;=97532^^78^910^6^^^^1
 ;;^UTILITY(U,$J,358.3,14689,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14689,1,2,0)
 ;;=2^97532
 ;;^UTILITY(U,$J,358.3,14689,1,3,0)
 ;;=3^COGNITIVE SKILLS DEVELOPMENT
 ;;^UTILITY(U,$J,358.3,14690,0)
 ;;=97537^^78^910^7^^^^1
 ;;^UTILITY(U,$J,358.3,14690,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14690,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,14690,1,3,0)
 ;;=3^COMMUNITY/WORK REINTEGRATION EA 15MIN
 ;;^UTILITY(U,$J,358.3,14691,0)
 ;;=97032^^78^910^8^^^^1
 ;;^UTILITY(U,$J,358.3,14691,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14691,1,2,0)
 ;;=2^97032
 ;;^UTILITY(U,$J,358.3,14691,1,3,0)
 ;;=3^ELECTRICAL STIMULATION EA 15MIN
 ;;^UTILITY(U,$J,358.3,14692,0)
 ;;=97014^^78^910^9^^^^1
 ;;^UTILITY(U,$J,358.3,14692,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14692,1,2,0)
 ;;=2^97014
 ;;^UTILITY(U,$J,358.3,14692,1,3,0)
 ;;=3^ELECTRIC STIMULATION THERAPY
 ;;^UTILITY(U,$J,358.3,14693,0)
 ;;=97116^^78^910^10^^^^1
 ;;^UTILITY(U,$J,358.3,14693,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14693,1,2,0)
 ;;=2^97116
 ;;^UTILITY(U,$J,358.3,14693,1,3,0)
 ;;=3^GAIT TRAINING THERAPY
 ;;^UTILITY(U,$J,358.3,14694,0)
 ;;=97150^^78^910^11^^^^1
 ;;^UTILITY(U,$J,358.3,14694,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14694,1,2,0)
 ;;=2^97150
 ;;^UTILITY(U,$J,358.3,14694,1,3,0)
 ;;=3^GRP THERAPEUTIC PROC,2 OR MORE
 ;;^UTILITY(U,$J,358.3,14695,0)
 ;;=97010^^78^910^12^^^^1
 ;;^UTILITY(U,$J,358.3,14695,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI0UA
